Drug Fever: Diagnostic Clues and Clinical Approach

Introduction

Drug fever is an adverse drug reaction characterized by fever coinciding with the administration of a drug and disappearing after discontinuation of the offending agent. It accounts for up to 10% of cases evaluated for Pyrexia of Unknown Origin (PUO). Recognizing drug fever avoids prolonged hospitalization, redundant lab tests, and inappropriate antimicrobial escalation.

Pathophysiologic Mechanisms

Drug fever can arise through several mechanisms:

  • Hypersensitivity Reactions: T-cell mediated or immune complex-driven systemic response (Most common).

  • Altered Thermoregulation: Increased metabolic heat production (e.g., Thyroid hormones) or reduced heat dissipation (e.g., Anticholinergics).

  • Administration-Related: Endotoxin contamination or local phlebitis.

  • Pharmacological Action: Jarisch-Herxheimer reaction following antimicrobial treatment for spirochetal infections.

Common Offending Medications

ClassSpecific Agents
Antimicrobials

Beta-lactams (Penicillins, Cephalosporins), Sulfonamides, Vancomycin, Amphotericin B.

Cardiovascular Agents

Methyldopa, Quinidine, Procainamide, Hydralazine.

Anticonvulsants

Phenytoin, Carbamazepine, Phenobarbital.

Other Drugs

Allopurinol, Heparin, NSAIDs, Chemotherapeutic agents.

Key Clinical Features

  • Relative Bradycardia (Faget Sign): Pulse rate remains inappropriately low despite high fever (though not universal).

  • Patient Appearance: Patients often appear paradoxically well despite high fevers ($> 39.0^\circ\text{C}$).

  • Associated Signs: Rash (maculopapular) in 20–30% of cases; mild eosinophilia on CBC.

  • Timeline: Can occur days to months after drug initiation (median time frame: 7 to 10 days).

+-------------------------------------------------------------------+
|                    DIAGNOSTIC ALGORITHM FOR DRUG FEVER            |
+-------------------------------------------------------------------+
|  1. Suspect drug fever in PUO with no clear infectious source.     |
|  2. Review medication administration record (MAR) timeline.       |
|  3. Discontinue non-essential or suspected culprit drugs.         |
|  4. Observe temperature response: Defervescence typically occurs  |
|     within 48 to 72 hours post-discontinuation.                  |
+-------------------------------------------------------------------+